Cargando…

Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease

Despite the evolution in inflammatory bowel disease (IBD) management during the last 20 years owing to the advent of new advanced therapies, anti-TNF agents still remain the cornerstone of therapy for both Crohn’s disease and ulcerative colitis. However, this does not only secure favorable outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orfanoudaki, Eleni, Foteinogiannopoulou, Kalliopi, Theodoraki, Eirini, Koutroubakis, Ioannis E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095227/ https://www.ncbi.nlm.nih.gov/pubmed/37048536 http://dx.doi.org/10.3390/jcm12072452

Ejemplares similares

Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
por: Theodoraki, Eirini, et al.
Publicado: (2021)

Keeping on the High Quality of Health Care in Greek Inflammatory Bowel Disease Patients in the SARS-CoV-2 Era
por: Foteinogiannopoulou, Kalliopi, et al.
Publicado: (2020)

Use of vedolizumab in a patient with chronic and refractory pouchitis
por: Orfanoudaki, Eleni, et al.
Publicado: (2018)

Solid extraintestinal malignancies in patients with inflammatory bowel disease
por: Mala, Anastasia, et al.
Publicado: (2021)

Crohn’s Disease-Like Features in a Patient With IgE and Selective IgG1 and IgG3 Deficiency
por: Drygiannakis, Ioannis, et al.
Publicado: (2023)

Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY
por: Zacharopoulou, Eirini, et al.
Publicado: (2022)

Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)

Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)

Lymphangiogenesis in Inflammatory Bowel Disease; A New Therapeutic Target?
por: Koutroubakis, Ioannis E, et al.
Publicado: (2016)

Pyoderma gangrenosum associated with chronic refractory pouchitis: a case successfully treated with infliximab
por: Koumaki, Dimitra, et al.
Publicado: (2020)

Anti-TNF Withdrawal in Inflammatory Bowel Disease
por: Torres, Joana, et al.
Publicado: (2016)

Classical and recent advances in the treatment of inflammatory bowel diseases
por: Sales-Campos, H., et al.
Publicado: (2014)

Recent advances in inflammatory bowel disease
por: Al Dulaimi, David
Publicado: (2015)

Recent advances in inflammatory bowel disease
por: Polewiczowska, Beata, et al.
Publicado: (2017)

Osteoclast: like giant cell undiferrentiated pancreatic tumor diagnosed by means of EUS guided FNA
por: Kalogeraki, Alexandra, et al.
Publicado: (2021)

Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis?
por: Mantaka, Aikaterini, et al.
Publicado: (2022)

Anti‐TNF‐induced lupus in patients with inflammatory bowel disease
por: Picardo, Sherman, et al.
Publicado: (2019)

Distinct features of circulating microparticles and their relationship with disease activity in inflammatory bowel disease
por: Voudoukis, Evangelos, et al.
Publicado: (2016)

Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF
por: Cachen, Laurie, et al.
Publicado: (2022)

Are We Ready for Proactive Therapeutic Drug Monitoring of Anti-TNF to Optimize Care of Patients With Inflammatory Bowel Disease?
por: Charabaty, Aline
Publicado: (2020)

Cyclin-dependent Kinase 9 as a Potential Target for Anti-TNF-resistant Inflammatory Bowel Disease
por: Omer, Omer S., et al.
Publicado: (2022)

Systematic review: genetic biomarkers associated with anti‐TNF treatment response in inflammatory bowel diseases
por: Bek, S., et al.
Publicado: (2016)

Potential Impact of Diet on Treatment Effect from Anti-TNF Drugs in Inflammatory Bowel Disease
por: Andersen, Vibeke, et al.
Publicado: (2017)

Mucosal gene expression changes induced by anti‐TNF treatment in inflammatory bowel disease patients
por: Milanesi, Elena, et al.
Publicado: (2019)

Specific T-Cell Subsets Can Predict the Efficacy of Anti-TNF Treatment in Inflammatory Bowel Diseases
por: Dulic, Sonja, et al.
Publicado: (2020)

Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy
por: Sochal, Marcin, et al.
Publicado: (2021)

Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
por: Mihai, Ioana Ruxandra, et al.
Publicado: (2023)

A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease
por: Aardoom, Martine A., et al.
Publicado: (2019)

Pott’s Puffy Tumor in an Inflammatory Bowel Disease Patient on Anti-TNF Therapy
por: Miri, Ahmad, et al.
Publicado: (2021)

Tu1549: IMPLEMENTATION AND SHORT-TERM ADVERSE EVENTS OF ANTI-SARSCOV-2 VACCINES IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTERNATIONAL WEB-BASED SURVEY
por: Revés, Joana, et al.
Publicado: (2022)

Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study
por: Oustamanolakis, Pantelis, et al.
Publicado: (2011)

Loss of response to anti‐TNFα agents depends on treatment duration in patients with inflammatory bowel disease
por: Schultheiss, Johannes P. D., et al.
Publicado: (2021)

A guide to preparation of patients with inflammatory bowel diseases for anti-TNF-α therapy
por: Chebli, Júlio Maria Fonseca, et al.
Publicado: (2014)

IgA Nephropathy in the Setting of Anti-TNF-α Therapy for Inflammatory Bowel Disease
por: Strobel, Thomas, et al.
Publicado: (2020)

Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
por: Salvador-Martín, Sara, et al.
Publicado: (2020)

Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
por: Salvador-Martín, Sara, et al.
Publicado: (2021)

Investigation of the effects of anti-TNF agents on hemoglobin levels in patients with inflammatory bowel disease
por: Okuyucu, Muhammed, et al.
Publicado: (2022)

Inflammatory bowel disease: recent advances on genetics and innate immunity
por: Karantanos, Theodoros, et al.
Publicado: (2011)

Recent Advance in Very Early Onset Inflammatory Bowel Disease
por: Shim, Jung Ok
Publicado: (2019)

Recent advance in very early-onset inflammatory bowel disease
por: Shim, Jung Ok
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l14n6ld5qfq2g6ikbaag16g6j6